血液透析启动与HDL蛋白组成的改变
本研究比较了143例近一年内启动血液透析的患者与110例晚期CKD患者的HDL相关蛋白,发现近期透析启动与8种HDL蛋白浓度升高相关,但胆固醇流出能力降低的趋势未达统计学显著。
要点
- 近期启动血液透析与8种HDL蛋白相对浓度升高相关。
- 升高的蛋白涉及炎症和脂质代谢通路。
- 胆固醇流出能力降低趋势未达统计学显著。
核心结论
- 与晚期CKD相比,近一年内启动血液透析与8种炎症和脂质代谢相关HDL蛋白浓度升高相关。
研究设计与样本
- 研究纳入143例近一年内启动血液透析的参与者与110例晚期CKD参与者,来自血液透析瘘管成熟研究。
- 采用靶向质谱法量化38种HDL相关蛋白相对于总HDL蛋白的浓度。
- 使用线性回归比较调整后HDL相关蛋白相对丰度,要求假发现率q值≤10%。
- 在80例参与者子集中评估血液透析启动与胆固醇流出能力的关联。
主要发现
- 调整人口学、合并症和其他临床特征后,8种HDL相关蛋白达到预设假发现阈值。
- 近期血液透析启动与血清淀粉样蛋白A1、A2、A4、血红蛋白-β、触珠蛋白相关蛋白、胆固醇酯转移蛋白、磷脂转移蛋白和载脂蛋白E的HDL相关浓度升高相关。
- 近期启动血液透析者胆固醇流出能力低于晚期CKD者的趋势未达统计学显著。
关键数值与推荐
- HDL相关蛋白相对丰度比较要求假发现率q值≤10%。
- 8种HDL相关蛋白达到预设假发现阈值。
临床怎么用
- 肾内科医生应关注血液透析启动对HDL蛋白组成和功能的潜在影响。
- 识别出的HDL蛋白可能有助于评估透析患者心血管风险,但需进一步研究。
局限性
- 胆固醇流出能力分析仅基于80例参与者子集。
- 研究为观察性设计,无法确定因果关系。
- 识别蛋白的临床意义尚不明确,需进一步研究。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND OBJECTIVES: HDL particles obtained from patients on chronic hemodialysis exhibit lower cholesterol efflux capacity and are enriched in inflammatory proteins compared with those in healthy individuals. Observed alterations in HDL proteins could be due to effects of CKD, but also may be influenced by the hemodialysis procedure, which stimulates proinflammatory and prothrombotic pathways. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: We compared HDL-associated proteins in 143 participants who initiated hemodialysis within the previous year with those of 110 participants with advanced CKD from the Hemodialysis Fistula Maturation Study. We quantified concentrations of 38 HDL-associated proteins relative to total HDL protein using targeted mass spectrometry assays that included a stable isotope-labeled internal standard. We used linear regression to compare the relative abundances of HDL-associated proteins after adjustment and required a false discovery rate q value ≤10% to control for multiple testing. We further assessed the association between hemodialysis initiation and cholesterol efflux capacity in a subset of 80 participants. RESULTS: After adjustment for demographics, comorbidities, and other clinical characteristics, eight HDL-associated proteins met the prespecified false discovery threshold for association. Recent hemodialysis initiation was associated with higher HDL-associated concentrations of serum amyloid A1, A2, and A4; hemoglobin-β; haptoglobin-related protein; cholesterylester transfer protein; phospholipid transfer protein; and apo E. The trend for participants recently initiating hemodialysis for lower cholesterol efflux capacity compared with individuals with advanced CKD did not reach statistical significance. CONCLUSIONS: Compared with advanced CKD, hemodialysis initiation within the previous year is associated with higher concentrations of eight HDL proteins related to inflammation and lipid metabolism. Identified associations differ from those recently observed for nondialysis-requiring CKD. Hemodialysis initiation may further impair cholesterol efflux capacity. Further work is needed to clarify the clinical significance of the identified proteins with respect to cardiovascular risk. PODCAST: This article contains a podcast at https://www.asn-online.org/media/podcast/CJASN/2018_07_25_CJASNPodcast_18_8_W.mp3.
引用
- Wang K, Zelnick LR, Hoofnagle AN, et al. Alteration of HDL Protein Composition with Hemodialysis Initiation. Clin J Am Soc Nephrol. 2018. PMID: 30045914. doi:10.2215/CJN.11321017
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。